Storia in 8 fonti

Bank of America spends more than $250 million on GLP-1s

CEO Brian Moynihan said he knows some employees will leave before reaping the health benefits.

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

businessinsider.comStai leggendo5 g fa

Bank of America spends more than $250 million on GLP-1s

CEO Brian Moynihan said he knows some employees will leave before reaping the health benefits.

originale

Timeline cronologica

qz.com

5 g fa

Bank of America spending $250M a year on GLP-1 weight loss drugs

Bank of America allocates $250M/year to GLP-1 drugs (13% of healthcare budget) for 211k employees. Corporate GLP-1 adoption signals healthcare cost shifts—tech managers must budget this growing line item as drugmakers expand employer coverage.

Leggi questa versione → originale

cnbc.com5 g fa

Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says

Bank of America allocates $250M yearly to GLP-1 drugs for 211,000 employees (13% of $2B healthcare budget). The scale signals enterprise confidence in preventive wellness ROI and workforce retention, reshaping benefit strategies across financial services.

Leggi questa versione → originale

newsbytesapp.com4 g fa

This bank spends $250M annually on weight-loss drugs for employees

Bank of America allocates over $250 million annually for GLP-1 weight loss drugs, CEO Brian Moynihan revealed, emphasizing the health benefits and long-term value for employees.

Leggi questa versione → originale

benzinga.com4 g fa

Bank of America Spends $250 Million a Year on Ozempic and Other GLP-1 Drugs, CEO Calls It 'a Good Investm

Bank of America spends over $250 million yearly on GLP-1 drugs, with CEO Brian Moynihan calling it a smart investment.

Leggi questa versione → originale

fortune.com3 g fa

Bank of America is splashing out $250 million a year on weight loss drugs for its staff: ‘We see a great…

Weight-loss drugs are becoming a popular perk, with almost a third of workers saying they’d even switch jobs for it. Bank of America has them covered.

Leggi questa versione → originale

mercoledì 5 agosto 2026·

businessinsider.com

Bank of America spends more than $250 million on GLP-1s

CEO Brian Moynihan said he knows some employees will leave before reaping the health benefits.

giovedì 6 agosto 2026·

newsbytesapp.com

This bank spends $250M annually on weight-loss drugs for employees

Bank of America allocates over $250 million annually for GLP-1 weight loss drugs, CEO Brian Moynihan revealed, emphasizing the health benefits and long-term value for employees.

giovedì 6 agosto 2026·

benzinga.com

Bank of America Spends $250 Million a Year on Ozempic and Other GLP-1 Drugs, CEO Calls It 'a Good Investm

Bank of America spends over $250 million yearly on GLP-1 drugs, with CEO Brian Moynihan calling it a smart investment.

giovedì 6 agosto 2026·

eleconomista.es

Bank of America defiende gastar 250 millones al año en fármacos contra la obesidad para sus trabajadores (y no es el único)

Bank of America considera que destinar más de 250 millones de dólares al año a financiar medicamentos contra la obesidad para sus empleados no es un coste extraordinario, sino una…

giovedì 6 agosto 2026·

independent.co.uk

Major bank spends $250 million a year on GLP-1 drugs for its employees, CEO says

GLP-1 drugs for weight loss are on the rise, with 11 percent of Americans saying they take one in a recent poll

venerdì 7 agosto 2026·

fortune.com

Bank of America is splashing out $250 million a year on weight loss drugs for its staff: ‘We see a great impact on employees,’ CEO says |…

Weight-loss drugs are becoming a popular perk, with almost a third of workers saying they’d even switch jobs for it. Bank of America has them covered.